Motherson Sumi says PLI scheme ‘very exciting’; bullish on India mfg opportunity
In terms of financing to meet growth expectations, the company said it will do so through internal accruals, debt and equity as necessary.
Incentives linked to government production (PLI) The program is “very exciting” and the huge opportunity in India could help the company exceed its 2025 annual target. Chaand Sehgal, chairman of auto parts giant Motherson Sumi Systems Ltd Vivek, on Monday summarized a comprehensive plan with a sales target of $360 billion.
Motherson Sumi Systems Ltd (MSSL) has a clear idea that no country should have more than 10% of its revenue, but it believes that India offers clear opportunities for manufacturing and wants to promote ‘Make in India’.
Vivek Chaand Sehgal, Chairman, MSSL, in an interview with PTI on “PLII announced by the Government of India” said, “The PLII announced by the Government of India is a very exciting program. Let us see what important role we can play here.”
Earlier this month, the government announced PLIs for these sectors. to revitalize the domestic manufacturing sector, incentives worth Rs 200 crore will be provided related to 10 sectors such as automotive, pharmaceuticals, communications, textiles, food, solar power and others.
SIAMM Automobile Industry Body Committed to allocate Rs 57,000 crore over the next five years to make the automobile industry a part of the global value chain.
Though it was MSSL that did not elaborate on the specific plans to achieve this, Sehgall said: “We have a clear idea that we don’t want any country to account for more than 10 percent of our total sales. On an optimistic note, the great opportunity is that things are so exciting in India. Our sales will actually expand to 360 which means sales will be over 10 countries/regions billion dollars.”
In its five-year plan, MSSL has set a target of achieving $36 billion in consolidated revenues by FY25, of which 75% will come from the automotive sector and 25% will come from the aerospace, logistics, health and medical sectors.
Chand also said that the company will bridge the $18 billion consolidated revenue gap in its next five-year plan, which is its FY20 target.
“We were hit at a very critical time in January and February (due to the coronavirus pandemic) and we are targeting $18 billion and 40% He added that ROCE (return on capital employed). Options to stop access.
“All of these opportunities still exist in the market,” he said, adding that he is confident the company will achieve its goals.
MSSL expects to invest $9 billion through 2025 as it grows its current business lines, adds new technologies, and diversifies into new non-automotive areas.
In terms of financing to meet growth expectations, the company said the goal will be met through internal accruals, debt and equity as necessary.
In the current financial year, the company has allocated Rs 200 crore for capital expenditure, which is likely to remain at the same level in the next financial year.
Blood.
Recommended Suppliers